Difference between revisions of "Team:Tuebingen/Basic Part"
| Line 224: | Line 224: | ||
<a href="https://2017.igem.org/Team:Tuebingen/Inspiration"style="margin-right:1.5em;">Inspiration</a> | <a href="https://2017.igem.org/Team:Tuebingen/Inspiration"style="margin-right:1.5em;">Inspiration</a> | ||
<a href="https://2017.igem.org/Team:Tuebingen/Demonstrate"style="margin-right:1.5em;">Results</a> | <a href="https://2017.igem.org/Team:Tuebingen/Demonstrate"style="margin-right:1.5em;">Results</a> | ||
| − | <a href="https://2017.igem.org/Team:Tuebingen/HP | + | <a href="https://2017.igem.org/Team:Tuebingen/HP"style="margin-right:1.5em;">Human Practice</a> |
<a href="https://2017.igem.org/Team:Tuebingen/Lab"style="margin-right:1.5em;">Lab</a> | <a href="https://2017.igem.org/Team:Tuebingen/Lab"style="margin-right:1.5em;">Lab</a> | ||
<a href="https://2017.igem.org/Team:Tuebingen/Attributions"style="margin-right:1.5em;">Attributions</a> | <a href="https://2017.igem.org/Team:Tuebingen/Attributions"style="margin-right:1.5em;">Attributions</a> | ||
Revision as of 03:12, 2 November 2017
basic parts
Basic Parts
SHV-1 is a β-lactamase that mediates resistance against ꞵ-lactams
CouL is a amide synthetase that catalyzes the bonding of the amide bonds in aminocoumarin antibiotics
CloL is a amide synthetase that catalyzes the bonding of the amide bonds in aminocoumarin antibiotics
β-lactam synthetase (BLS) catalyzes the formation of the β-lactam ring of clavulanic acid
The BLS mutant is a rationally designed mutant of the β-lactam synthetase
Gyrase B (GyrB)is a type II topoisomerase
Gyrase B (GyrB)is a type II topoisomerase
